apollo
0
Written By Bayyarapu Mahesh Kumar , M Pharmacy
Reviewed By Santoshini Reddy G , M Pharmacy
Last Updated Oct 9, 2024 | 12:37 PM IST
Peg-Religrast 6Mg/0.6Ml Inj belongs to the class of medicine called hematopoietic agents used in the treatment of neutropenia. It helps reduce the chances of infection in cancer patients by stimulating the formation of white blood cells. Common side effects include nausea, headaches, bone pain, pain in the extremity, and injection site reactions.
Read more
Prescription drug

Whats That

tooltip
Prescription drug
 Trailing icon
Consult Doctor

Manufacturer/Marketer

Reliance Formulation Pvt Ltd

Consume Type

PARENTERAL

Return Policy

Not Returnable

Expires on or after

Jan-27

for this medicine

About Peg-Religrast 6Mg/0.6Ml Inj

Peg-Religrast 6Mg/0.6Ml Inj belongs to the class of medicine called 'hematopoietic agent' used to treat neutropenia, a deficiency of specific white blood cells caused by cancer, bone marrow transplant, chemotherapy, or other diseases. Peg-Religrast 6Mg/0.6Ml Inj helps reduce the chance of infection in cancer patients and those receiving chemotherapy medicines. Neutropenia is a condition in which the quantity of neutrophils (white blood cells) in the blood is reduced.

Peg-Religrast 6Mg/0.6Ml Inj contains 'Pegfilgrastim,' a growth factor that stimulates the formation of white blood cells and helps reduce the chances of infection in cancer patients receiving chemotherapy.

Peg-Religrast 6Mg/0.6Ml Inj will be administered by a healthcare professional. Sometimes, you may experience injection site responses such as pain, redness, or swelling. You may also experience nausea, headaches, bone pain and pain in the extremity. Most of these side effects do not necessitate medical treatment and will gradually fade over time. However, if you suffer these side effects regularly, you should consult your doctor.

Do not use Peg-Religrast 6Mg/0.6Ml Inj without the doctor's advice if you have a skin reaction or irritation to any medicine. Consult your doctor before using the Peg-Religrast 6Mg/0.6Ml Inj if you are pregnant or breastfeeding. Let your doctor know if you suffer from renal dysfunction, blood cancer, or leucocytosis (high white blood cell count). Regular blood tests are recommended to check the number of white blood cells in the body. Keep your doctor informed about your medical condition and all the medicines you take to rule out any side effects.

Uses of Peg-Religrast 6Mg/0.6Ml Inj

Treatment of Neutropenia

Medicinal Benefits

Peg-Religrast 6Mg/0.6Ml Inj contains 'Pegfilgrastim,' which is a growth factor. It belongs to the cytokine family of proteins and is extremely similar to a natural protein (granulocyte-colony stimulating factor) produced by the body. Peg-Religrast 6Mg/0.6Ml Inj acts by encouraging the bone marrow to generate more white blood cells, aiding infection resistance. Peg-Religrast 6Mg/0.6Ml Inj is used to boost white blood cell count following cancer treatment or chemotherapy, bone marrow transplantation, severe persistent neutropenia, neutropenia in HIV patients, and before stem cell donation.

Directions for Use

Peg-Religrast 6Mg/0.6Ml Inj will be administered by a healthcare professional; do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Peg-Religrast 6Mg/0.6Ml Inj

  • Nausea
  • Headaches
  • Bone pain
  • Pain in extremity
  • Pain at the site of injection

Drug Warnings

Do not use Peg-Religrast 6Mg/0.6Ml Inj without the doctor's advice if you had a skin reaction or irritation to any medicine. Consult your doctor before using Peg-Religrast 6Mg/0.6Ml Inj if you are pregnant or breastfeeding. Let your doctor know if you are suffering from renal dysfunction, blood cancer, leucocytosis (high white blood cell count). Keep your doctor informed about your medical condition and all the medicines you are taking to rule out any side effects. Regular blood tests will be taken to monitor the number of white blood cells in the body. Peg-Religrast 6Mg/0.6Ml Inj is a cold chain medicine, and so it has to be stored in the refrigerator between 2-8 degrees Celsius else its efficacy might get lost.

Drug Interactions

Drug-Drug Interactions: Peg-Religrast 6Mg/0.6Ml Inj may have interaction with medicines used to treat cancer (e.g. cladribine) and other hematopoietic agents (e.g. filgrastim).

Drug-Food Interactions:  Limit or quit the consumption of alcohol.

Drug-Disease Interactions: Peg-Religrast 6Mg/0.6Ml Inj may cause interactions with disease conditions such as glomerulonephritis (acute inflammation of the kidney), leucocytosis (high white blood cell count) and myeloid tumours (cancer).

Drug-Drug Interactions Checker List

  • CLADRIBINE
  • FILGRASTIM

Habit Forming

No

Diet & Lifestyle Advise

  • Consume a well-balanced and healthy food to aid in your recovery.
  • Avoid eating processed food or frozen food. 
  • Consume antioxidant-rich foods such as berries, spinach, kidney beans, dark chocolate, and so on.
  • Flavonoid-rich foods aid in the reduction of inflammation. Soy, berries, broccoli, grapes, and green tea are examples.
  • Limit or quit the consumption of alcohol.
  • Quit smoking.

Special Advise

  • Monitoring of (CBC) complete blood count during therapy is recommended.
  • While using Peg-Religrast 6Mg/0.6Ml Inj, do not get any immunizations or vaccinations unless your doctor has approved them.

Disease/Condition Glossary

Neutropenia: Neutropenia is characterized as a lower than the normal number of neutrophils (a type of white blood cell). White blood cells protect the body from infections. Without enough neutrophils, the body cannot fight bacteria, increasing the risk of many illnesses. Neutropenia can be caused by various conditions, including cancers like leukaemia, cancer treatment like radiotherapy, and infections like HIV or hepatitis.

bannner image

Alcohol

Caution

It is unknown whether consuming alcohol with Peg-Religrast 6Mg/0.6Ml Inj is safe. However, as a precaution, it is best to avoid or limit alcohol consumption.

bannner image

Pregnancy

Caution

Pregnancy Category C. It should be used in pregnant women only if clinically needed, and the benefits outweigh the risks. Please consult your doctor.

bannner image

Breast Feeding

Caution

It is unknown whether Peg-Religrast 6Mg/0.6Ml Inj passes into the breast milk. Please seek medical advice from your doctor if you are breastfeeding before taking Peg-Religrast 6Mg/0.6Ml Inj.

bannner image

Driving

Safe if prescribed

The ability to drive or utilize machines is unaffected by Peg-Religrast 6Mg/0.6Ml Inj.

bannner image

Liver

Caution

Consult your doctor if you have liver problems.

bannner image

Kidney

Caution

Caution should be exercised while using Peg-Religrast 6Mg/0.6Ml Inj in patients with renal dysfunction. Monitoring of patients with renal dysfunction is recommended.

bannner image

Children

Caution

Please consult your doctor if you have any concerns regarding the usage of Peg-Religrast 6Mg/0.6Ml Inj in children.

Country of origin

India

Manufacturer/Marketer address

Dhirubhai Ambani Life Sciences Centre, R-282, TTC Area of MIDC, Thane-Belapur Road, Rabale, Navi Mumbai 400 701
Other Info - PEG0090

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Peg-Religrast 6Mg/0.6Ml Inj belongs to the class of medicine called 'hematopoietic agent' used to treat neutropenia, a deficiency of specific white blood cells caused by cancer, bone marrow transplant, chemotherapy, or other diseases.
Peg-Religrast 6Mg/0.6Ml Inj contains 'Pegfilgrastim,' which is a growth factor that stimulates the formation of white blood cells and helps to reduce the chances of infection in cancer patients receiving chemotherapy.
This medication should not be used in individuals who have a known allergy to filgrastim, pegfilgrastim, or any of the inactive components present in it.
Yes, Peg-Religrast 6Mg/0.6Ml Inj may interfere with certain lab tests, such as bone imaging and blood testing, potentially resulting in incorrect test findings. Make sure your doctor and laboratory personnel are aware that you take Peg-Religrast 6Mg/0.6Ml Inj.
Peg-Religrast 6Mg/0.6Ml Inj may sometimes cause capillary leak syndrome, a condition that causes blood leakage from small blood vessels. Inform your doctor immediately if you notice difficulty breathing, swelling, a feeling of fullness, and tiredness.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
icon image

Keep Refrigerated. Do not freeze.Prepaid payment required.

Add to Cart